

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * exogenous drug catabolic process (GO:0042738) | 7.53642895 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.38384161 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.38384161 |
| 4 | * drug catabolic process (GO:0042737) | 7.35021924 |
| 5 | omega-hydroxylase P450 pathway (GO:0097267) | 7.13084944 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.09035184 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.09035184 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.64308317 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.57612775 |
| 10 | * drug metabolic process (GO:0017144) | 6.08086272 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.00239738 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 6.00239738 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 6.00239738 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.87995056 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.74505617 |
| 16 | urea cycle (GO:0000050) | 5.70774532 |
| 17 | urea metabolic process (GO:0019627) | 5.70774532 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.64594375 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 5.64296498 |
| 20 | glyoxylate metabolic process (GO:0046487) | 5.53819132 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.50070996 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.39555657 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.27048165 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.23836383 |
| 25 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.19671126 |
| 26 | cysteine metabolic process (GO:0006534) | 5.19420908 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.18906771 |
| 28 | protein carboxylation (GO:0018214) | 5.17313234 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17313234 |
| 30 | regulation of cholesterol esterification (GO:0010872) | 5.12006601 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 5.09718157 |
| 32 | regulation of protein activation cascade (GO:2000257) | 5.08184910 |
| 33 | complement activation, alternative pathway (GO:0006957) | 5.07547720 |
| 34 | bile acid metabolic process (GO:0008206) | 5.01923813 |
| 35 | ethanol metabolic process (GO:0006067) | 4.98630404 |
| 36 | reverse cholesterol transport (GO:0043691) | 4.96212120 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.95997417 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.86349146 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.86349146 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.86349146 |
| 41 | phospholipid efflux (GO:0033700) | 4.83639566 |
| 42 | aromatic amino acid family metabolic process (GO:0009072) | 4.83359183 |
| 43 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.82074809 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81030041 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.78981599 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.78171979 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.78171979 |
| 48 | regulation of complement activation (GO:0030449) | 4.72376138 |
| 49 | oxidative demethylation (GO:0070989) | 4.71880928 |
| 50 | hormone catabolic process (GO:0042447) | 4.68646154 |
| 51 | tyrosine metabolic process (GO:0006570) | 4.67082452 |
| 52 | intestinal absorption (GO:0050892) | 4.66925570 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.66361424 |
| 54 | triglyceride homeostasis (GO:0070328) | 4.66361424 |
| 55 | phenylpropanoid metabolic process (GO:0009698) | 4.63743237 |
| 56 | angiotensin maturation (GO:0002003) | 4.58810372 |
| 57 | alkaloid metabolic process (GO:0009820) | 4.57864539 |
| 58 | amino-acid betaine metabolic process (GO:0006577) | 4.57276463 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.52053191 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 4.51290815 |
| 61 | lysine catabolic process (GO:0006554) | 4.50403690 |
| 62 | lysine metabolic process (GO:0006553) | 4.50403690 |
| 63 | cholesterol efflux (GO:0033344) | 4.40731905 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 4.39882684 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 4.38417136 |
| 66 | cellular glucuronidation (GO:0052695) | 4.33649590 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.24455583 |
| 68 | coenzyme catabolic process (GO:0009109) | 4.23669015 |
| 69 | negative regulation of hemostasis (GO:1900047) | 4.23506059 |
| 70 | negative regulation of blood coagulation (GO:0030195) | 4.23506059 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 4.21982223 |
| 72 | glycine metabolic process (GO:0006544) | 4.20850416 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.16052399 |
| 74 | amine catabolic process (GO:0009310) | 4.15735900 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.15735900 |
| 76 | glutamate metabolic process (GO:0006536) | 4.15626012 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 4.15420398 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.07630972 |
| 79 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.06289771 |
| 80 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.06289771 |
| 81 | intestinal cholesterol absorption (GO:0030299) | 4.04823633 |
| 82 | regulation of plasminogen activation (GO:0010755) | 4.03451092 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 4.02813582 |
| 84 | arginine metabolic process (GO:0006525) | 4.00128867 |
| 85 | regulation of bile acid biosynthetic process (GO:0070857) | 3.99923721 |
| 86 | cellular modified amino acid catabolic process (GO:0042219) | 3.97313709 |
| 87 | flavonoid metabolic process (GO:0009812) | 3.94703084 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94228020 |
| 89 | ethanol oxidation (GO:0006069) | 3.93595159 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.93424191 |
| 91 | acute-phase response (GO:0006953) | 3.92655191 |
| 92 | NADH metabolic process (GO:0006734) | 3.92444651 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.91033398 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.88060659 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.87936534 |
| 96 | negative regulation of coagulation (GO:0050819) | 3.87789187 |
| 97 | fibrinolysis (GO:0042730) | 3.86039609 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 3.85738289 |
| 99 | uronic acid metabolic process (GO:0006063) | 3.84933597 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.84933597 |
| 101 | sterol homeostasis (GO:0055092) | 3.84880036 |
| 102 | aldehyde catabolic process (GO:0046185) | 3.81809616 |
| 103 | ketone body metabolic process (GO:1902224) | 3.80573446 |
| 104 | protein-lipid complex assembly (GO:0065005) | 3.79511274 |
| 105 | negative regulation of lipase activity (GO:0060192) | 3.79503182 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.79046136 |
| 107 | regulation of cholesterol homeostasis (GO:2000188) | 3.78823165 |
| 108 | fructose metabolic process (GO:0006000) | 3.76911093 |
| 109 | negative regulation of wound healing (GO:0061045) | 3.73547682 |
| 110 | plasma lipoprotein particle organization (GO:0071827) | 3.73336819 |
| 111 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.71676370 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.69432592 |
| 113 | cofactor catabolic process (GO:0051187) | 3.67999234 |
| 114 | organic acid catabolic process (GO:0016054) | 3.67083163 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.67083163 |
| 116 | lipoprotein metabolic process (GO:0042157) | 3.66596234 |
| 117 | regulation of humoral immune response (GO:0002920) | 3.63921266 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.63459610 |
| 119 | complement activation, classical pathway (GO:0006958) | 3.58032726 |
| 120 | protein activation cascade (GO:0072376) | 3.57069376 |
| 121 | epoxygenase P450 pathway (GO:0019373) | 3.56069649 |
| 122 | protein-lipid complex subunit organization (GO:0071825) | 3.56012382 |
| 123 | acetyl-CoA metabolic process (GO:0006084) | 3.55398091 |
| 124 | complement activation (GO:0006956) | 3.54930061 |
| 125 | drug transmembrane transport (GO:0006855) | 3.52019926 |
| 126 | S-adenosylmethionine metabolic process (GO:0046500) | 3.47820103 |
| 127 | heme transport (GO:0015886) | 3.43709099 |
| 128 | diacylglycerol metabolic process (GO:0046339) | 3.43343045 |
| 129 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.41022437 |
| 130 | renal system process involved in regulation of blood volume (GO:0001977) | 3.40775257 |
| 131 | lipoprotein transport (GO:0042953) | 3.39557268 |
| 132 | oxaloacetate metabolic process (GO:0006107) | 3.35065988 |
| 133 | negative regulation of protein activation cascade (GO:2000258) | 3.33830519 |
| 134 | * xenobiotic metabolic process (GO:0006805) | 3.32514467 |
| 135 | proline metabolic process (GO:0006560) | 3.31799657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.27624296 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13961771 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.86632014 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45199072 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.20569779 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.01710104 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.84205946 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.97697709 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89080858 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.19195406 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02827542 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7722086 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93198112 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74693715 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.69018943 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62765656 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55890229 |
| 18 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52639826 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47601338 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46027218 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.44650018 |
| 22 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36888254 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31476869 |
| 24 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27257627 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25172263 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23880649 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22496058 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.17128268 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13697246 |
| 30 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13084782 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09192191 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06966640 |
| 33 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05512502 |
| 34 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01295478 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01094745 |
| 36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00011775 |
| 37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.90609398 |
| 38 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89821525 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.89048155 |
| 40 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87536163 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85702689 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84095779 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83943668 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82893907 |
| 45 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.82783277 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82679882 |
| 47 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82669312 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82144510 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81682284 |
| 50 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79902024 |
| 51 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79284400 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78663864 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78532095 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77774162 |
| 55 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.76779527 |
| 56 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76221060 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75632054 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75051727 |
| 59 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.74966052 |
| 60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74445955 |
| 61 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74219657 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74191179 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73742761 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73425316 |
| 65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73294234 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72977408 |
| 67 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.72518822 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71660517 |
| 69 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.71630679 |
| 70 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.71557554 |
| 71 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71074076 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69591561 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67606875 |
| 74 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.66975314 |
| 75 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.65784633 |
| 76 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.64988016 |
| 77 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.64535017 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.64303266 |
| 79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63612718 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.63374724 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.62909114 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62740157 |
| 83 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62642165 |
| 84 | P300_27268052_Chip-Seq_Bcells_Human | 0.61372785 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61009123 |
| 86 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60848293 |
| 87 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60848293 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.60571381 |
| 89 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.60275484 |
| 90 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60263453 |
| 91 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58734035 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57078563 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56838580 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56798875 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.54989865 |
| 96 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53941089 |
| 97 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53893251 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53217031 |
| 99 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.53182483 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53159021 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.51589686 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51438668 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51320611 |
| 104 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50854360 |
| 105 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50569907 |
| 106 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49644643 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49416634 |
| 108 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49184404 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.48610545 |
| 110 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47236532 |
| 111 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.46168468 |
| 112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.44908081 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44295923 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43970176 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.43790351 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.43567543 |
| 117 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43074720 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43015529 |
| 119 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42970200 |
| 120 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40775804 |
| 121 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.40330048 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40272600 |
| 123 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.39035437 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.38552575 |
| 125 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36830160 |
| 126 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36794961 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.36727921 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36384721 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36280323 |
| 130 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.36177074 |
| 131 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35630327 |
| 132 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.34905073 |
| 133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34856777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.21734132 |
| 2 | MP0005360_urolithiasis | 7.85785666 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.42650930 |
| 4 | MP0005365_abnormal_bile_salt | 6.04374945 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.27332185 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.07636633 |
| 7 | MP0003252_abnormal_bile_duct | 3.97481930 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.61220283 |
| 9 | MP0009840_abnormal_foam_cell | 3.42378356 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.95785248 |
| 11 | MP0005083_abnormal_biliary_tract | 2.93924130 |
| 12 | MP0005332_abnormal_amino_acid | 2.71762226 |
| 13 | MP0003195_calcinosis | 2.59290819 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.32831936 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.19646156 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.10705615 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.08352217 |
| 18 | MP0003868_abnormal_feces_composition | 1.93269075 |
| 19 | MP0002138_abnormal_hepatobiliary_system | 1.88569523 |
| 20 | MP0003183_abnormal_peptide_metabolism | 1.83090536 |
| 21 | * MP0005319_abnormal_enzyme/_coenzyme | 1.72650739 |
| 22 | MP0001764_abnormal_homeostasis | 1.62966377 |
| 23 | MP0009697_abnormal_copulation | 1.61446589 |
| 24 | MP0005451_abnormal_body_composition | 1.53231540 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51603821 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.38549952 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.27353141 |
| 28 | MP0003011_delayed_dark_adaptation | 1.26894493 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.21390471 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.19964367 |
| 31 | MP0004147_increased_porphyrin_level | 1.17537961 |
| 32 | MP0009379_abnormal_foot_pigmentation | 1.17430853 |
| 33 | MP0003186_abnormal_redox_activity | 1.15614918 |
| 34 | MP0000598_abnormal_liver_morphology | 1.13770509 |
| 35 | MP0005409_darkened_coat_color | 1.07278251 |
| 36 | MP0005647_abnormal_sex_gland | 1.03796414 |
| 37 | MP0002254_reproductive_system_inflammat | 1.03584312 |
| 38 | MP0000604_amyloidosis | 1.03204193 |
| 39 | MP0009764_decreased_sensitivity_to | 1.03023552 |
| 40 | MP0003879_abnormal_hair_cell | 0.98551202 |
| 41 | MP0003866_abnormal_defecation | 0.98069453 |
| 42 | MP0009763_increased_sensitivity_to | 0.97521585 |
| 43 | MP0005636_abnormal_mineral_homeostasis | 0.95613542 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.87771462 |
| 45 | MP0009642_abnormal_blood_homeostasis | 0.87132508 |
| 46 | MP0002132_abnormal_respiratory_system | 0.86792817 |
| 47 | MP0008469_abnormal_protein_level | 0.86125614 |
| 48 | MP0005408_hypopigmentation | 0.81398367 |
| 49 | MP0005670_abnormal_white_adipose | 0.81311001 |
| 50 | MP0010368_abnormal_lymphatic_system | 0.81098677 |
| 51 | MP0009765_abnormal_xenobiotic_induced | 0.79343729 |
| 52 | MP0005376_homeostasis/metabolism_phenot | 0.78961052 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.77389778 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 0.76794303 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.75724846 |
| 56 | MP0000477_abnormal_intestine_morphology | 0.75010847 |
| 57 | MP0001664_abnormal_digestion | 0.73985807 |
| 58 | MP0009785_altered_susceptibility_to | 0.71791646 |
| 59 | MP0002971_abnormal_brown_adipose | 0.71584224 |
| 60 | MP0001663_abnormal_digestive_system | 0.69476995 |
| 61 | MP0009053_abnormal_anal_canal | 0.68157016 |
| 62 | MP0002822_catalepsy | 0.67576106 |
| 63 | MP0005266_abnormal_metabolism | 0.67397116 |
| 64 | MP0005334_abnormal_fat_pad | 0.67131943 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 0.66765394 |
| 66 | MP0005058_abnormal_lysosome_morphology | 0.65558167 |
| 67 | MP0001765_abnormal_ion_homeostasis | 0.65486217 |
| 68 | MP0005448_abnormal_energy_balance | 0.62359748 |
| 69 | MP0005535_abnormal_body_temperature | 0.61425797 |
| 70 | MP0000678_abnormal_parathyroid_gland | 0.61171861 |
| 71 | MP0004130_abnormal_muscle_cell | 0.61125393 |
| 72 | MP0001756_abnormal_urination | 0.60076110 |
| 73 | MP0003690_abnormal_glial_cell | 0.58826956 |
| 74 | MP0001661_extended_life_span | 0.58296248 |
| 75 | MP0003329_amyloid_beta_deposits | 0.58069760 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 0.57987746 |
| 77 | MP0000566_synostosis | 0.57985193 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 0.54183226 |
| 79 | MP0005381_digestive/alimentary_phenotyp | 0.53756030 |
| 80 | MP0000639_abnormal_adrenal_gland | 0.53607807 |
| 81 | MP0000490_abnormal_crypts_of | 0.53488731 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.53336377 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.52903066 |
| 84 | MP0003718_maternal_effect | 0.52119077 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 0.51285604 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.50001929 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.49924545 |
| 88 | MP0003638_abnormal_response/metabolism_ | 0.47455527 |
| 89 | MP0005395_other_phenotype | 0.46483794 |
| 90 | MP0005023_abnormal_wound_healing | 0.46261103 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.43592868 |
| 92 | MP0005166_decreased_susceptibility_to | 0.41883676 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.40977331 |
| 94 | MP0003953_abnormal_hormone_level | 0.40952907 |
| 95 | MP0001873_stomach_inflammation | 0.40559136 |
| 96 | MP0002796_impaired_skin_barrier | 0.40488543 |
| 97 | MP0005025_abnormal_response_to | 0.39759373 |
| 98 | MP0003724_increased_susceptibility_to | 0.39415966 |
| 99 | MP0004858_abnormal_nervous_system | 0.39310950 |
| 100 | * MP0008873_increased_physiological_sensi | 0.39287583 |
| 101 | MP0002928_abnormal_bile_duct | 0.39120007 |
| 102 | MP0003436_decreased_susceptibility_to | 0.38879943 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.38179475 |
| 104 | MP0009384_cardiac_valve_regurgitation | 0.36972958 |
| 105 | MP0000579_abnormal_nail_morphology | 0.36414309 |
| 106 | MP0003075_altered_response_to | 0.36102976 |
| 107 | MP0009115_abnormal_fat_cell | 0.35608816 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.34580928 |
| 109 | * MP0008874_decreased_physiological_sensi | 0.33352284 |
| 110 | MP0000462_abnormal_digestive_system | 0.32762865 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.32720579 |
| 112 | MP0000249_abnormal_blood_vessel | 0.32174905 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.31827763 |
| 114 | MP0000467_abnormal_esophagus_morphology | 0.31749557 |
| 115 | MP0002168_other_aberrant_phenotype | 0.31481317 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.30471210 |
| 117 | MP0009672_abnormal_birth_weight | 0.29754439 |
| 118 | MP0001881_abnormal_mammary_gland | 0.29590826 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.29555713 |
| 120 | MP0006082_CNS_inflammation | 0.29335193 |
| 121 | MP0001243_abnormal_dermal_layer | 0.29236554 |
| 122 | MP0004883_abnormal_blood_vessel | 0.28158715 |
| 123 | MP0002970_abnormal_white_adipose | 0.28136733 |
| 124 | MP0003453_abnormal_keratinocyte_physiol | 0.27450979 |
| 125 | MP0002060_abnormal_skin_morphology | 0.27076617 |
| 126 | MP0000538_abnormal_urinary_bladder | 0.26941672 |
| 127 | MP0002166_altered_tumor_susceptibility | 0.26890184 |
| 128 | MP0002089_abnormal_postnatal_growth/wei | 0.26747179 |
| 129 | MP0003300_gastrointestinal_ulcer | 0.26656414 |
| 130 | MP0004043_abnormal_pH_regulation | 0.26625899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.26033513 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.17636982 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.15825032 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.72694650 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.70946677 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.34217387 |
| 7 | Xanthomatosis (HP:0000991) | 6.31000806 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.43401643 |
| 9 | Complement deficiency (HP:0004431) | 5.04061247 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.94933175 |
| 11 | Hyperammonemia (HP:0001987) | 4.60937530 |
| 12 | Joint hemorrhage (HP:0005261) | 4.57328131 |
| 13 | Epidermoid cyst (HP:0200040) | 4.53423826 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.50236513 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48594711 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.31459751 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28555988 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24884491 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 4.21943993 |
| 20 | Hyperglycinemia (HP:0002154) | 4.21494022 |
| 21 | Fat malabsorption (HP:0002630) | 4.21171269 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.20857428 |
| 23 | Ketosis (HP:0001946) | 4.18350610 |
| 24 | Hyperglycinuria (HP:0003108) | 3.96528806 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 3.95386127 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.88654892 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88654892 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.87672800 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.85568034 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.71597850 |
| 31 | Abnormality of complement system (HP:0005339) | 3.68680908 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.63182554 |
| 33 | Nephritis (HP:0000123) | 3.62189370 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37641786 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.37159971 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30599851 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13458938 |
| 38 | Steatorrhea (HP:0002570) | 3.01643001 |
| 39 | Spontaneous abortion (HP:0005268) | 3.00148885 |
| 40 | Ketoacidosis (HP:0001993) | 2.98900621 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.94269719 |
| 42 | Delayed CNS myelination (HP:0002188) | 2.94027155 |
| 43 | Acanthocytosis (HP:0001927) | 2.91910713 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.90411972 |
| 45 | Myocardial infarction (HP:0001658) | 2.84098712 |
| 46 | Metabolic acidosis (HP:0001942) | 2.83688411 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.78070876 |
| 48 | Abnormality of purine metabolism (HP:0004352) | 2.77404389 |
| 49 | Skin nodule (HP:0200036) | 2.76546802 |
| 50 | Malnutrition (HP:0004395) | 2.62682059 |
| 51 | Lethargy (HP:0001254) | 2.61381806 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.60789390 |
| 53 | Vascular calcification (HP:0004934) | 2.59942620 |
| 54 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.56747506 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.56747506 |
| 56 | Ileus (HP:0002595) | 2.56120915 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.52428871 |
| 58 | Widely patent fontanelles and sutures (HP:0004492) | 2.48827256 |
| 59 | Abnormal gallbladder morphology (HP:0012437) | 2.45374718 |
| 60 | Cholecystitis (HP:0001082) | 2.42732464 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.42732464 |
| 62 | Gout (HP:0001997) | 2.41902473 |
| 63 | Cholelithiasis (HP:0001081) | 2.40601258 |
| 64 | Spastic diplegia (HP:0001264) | 2.40386071 |
| 65 | Glomerulonephritis (HP:0000099) | 2.40172752 |
| 66 | Cerebral edema (HP:0002181) | 2.39181598 |
| 67 | Irritability (HP:0000737) | 2.35582443 |
| 68 | Hyperphosphaturia (HP:0003109) | 2.31810383 |
| 69 | Amyloidosis (HP:0011034) | 2.30488079 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.29897695 |
| 71 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.27071350 |
| 72 | Mitral stenosis (HP:0001718) | 2.25957665 |
| 73 | Poikilocytosis (HP:0004447) | 2.25606024 |
| 74 | Proximal tubulopathy (HP:0000114) | 2.22859169 |
| 75 | Neonatal onset (HP:0003623) | 2.22583259 |
| 76 | Purpura (HP:0000979) | 2.22528165 |
| 77 | Late onset (HP:0003584) | 2.21676053 |
| 78 | Esophageal varix (HP:0002040) | 2.20770603 |
| 79 | Nephrolithiasis (HP:0000787) | 2.19425698 |
| 80 | Gingival bleeding (HP:0000225) | 2.19124221 |
| 81 | Osteomalacia (HP:0002749) | 2.18704478 |
| 82 | Pancreatitis (HP:0001733) | 2.17922797 |
| 83 | Hypophosphatemia (HP:0002148) | 2.13833637 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.13408098 |
| 85 | Hydroxyprolinuria (HP:0003080) | 2.13408098 |
| 86 | Brushfield spots (HP:0001088) | 2.13275658 |
| 87 | Confusion (HP:0001289) | 2.13023306 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.12607266 |
| 89 | Abnormality of vitamin B metabolism (HP:0004340) | 2.11690130 |
| 90 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.10901135 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 2.10598154 |
| 92 | Menorrhagia (HP:0000132) | 2.08857781 |
| 93 | Vomiting (HP:0002013) | 2.08166939 |
| 94 | Abdominal distention (HP:0003270) | 2.07867654 |
| 95 | Enlarged kidneys (HP:0000105) | 2.05457044 |
| 96 | Facial shape deformation (HP:0011334) | 2.05119401 |
| 97 | Potter facies (HP:0002009) | 2.05119401 |
| 98 | Cerebral palsy (HP:0100021) | 2.05101706 |
| 99 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.04250723 |
| 100 | Pigmentary retinal degeneration (HP:0001146) | 2.03783384 |
| 101 | Generalized aminoaciduria (HP:0002909) | 2.01258078 |
| 102 | Thrombophlebitis (HP:0004418) | 2.01180808 |
| 103 | Opisthotonus (HP:0002179) | 2.00022556 |
| 104 | Abnormality of the gallbladder (HP:0005264) | 1.99448660 |
| 105 | Hemorrhage of the eye (HP:0011885) | 1.98550332 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98516174 |
| 107 | Chronic diarrhea (HP:0002028) | 1.96049876 |
| 108 | Rickets (HP:0002748) | 1.95336282 |
| 109 | Megaloblastic anemia (HP:0001889) | 1.94717253 |
| 110 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.92760382 |
| 111 | Alkalosis (HP:0001948) | 1.92559206 |
| 112 | Elevated alkaline phosphatase (HP:0003155) | 1.92430917 |
| 113 | Nausea (HP:0002018) | 1.92239206 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.91774324 |
| 115 | Increased purine levels (HP:0004368) | 1.91530889 |
| 116 | Hyperuricemia (HP:0002149) | 1.91530889 |
| 117 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90638271 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.90201464 |
| 119 | Pulmonary embolism (HP:0002204) | 1.86916266 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.86687001 |
| 121 | Reticulocytosis (HP:0001923) | 1.84326862 |
| 122 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83490321 |
| 123 | Glycosuria (HP:0003076) | 1.82483027 |
| 124 | Abnormality of urine glucose concentration (HP:0011016) | 1.82483027 |
| 125 | Hypophosphatemic rickets (HP:0004912) | 1.82366552 |
| 126 | Abnormal tarsal ossification (HP:0008369) | 1.82307676 |
| 127 | Hyperglycemia (HP:0003074) | 1.81632232 |
| 128 | Renal cortical cysts (HP:0000803) | 1.81560215 |
| 129 | Elevated hepatic transaminases (HP:0002910) | 1.79583794 |
| 130 | Hyperactive renin-angiotensin system (HP:0000841) | 1.77007191 |
| 131 | Flat acetabular roof (HP:0003180) | 1.76931479 |
| 132 | Wide cranial sutures (HP:0010537) | 1.75259932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.67585627 |
| 2 | ACVR1B | 5.27968578 |
| 3 | ERN1 | 4.38443287 |
| 4 | FGFR4 | 4.33974114 |
| 5 | SIK1 | 4.18450616 |
| 6 | TAOK3 | 3.15605541 |
| 7 | ERBB4 | 3.01552238 |
| 8 | INSRR | 2.89044948 |
| 9 | MST1R | 2.79321229 |
| 10 | FRK | 2.40263418 |
| 11 | PKN2 | 2.27835926 |
| 12 | MAP2K4 | 2.19076509 |
| 13 | PRPF4B | 2.07171874 |
| 14 | MAPK11 | 1.95089057 |
| 15 | FLT3 | 1.79389178 |
| 16 | LATS1 | 1.77297168 |
| 17 | PTK6 | 1.74040246 |
| 18 | PIK3CG | 1.72186721 |
| 19 | TRIB3 | 1.62967901 |
| 20 | TYK2 | 1.60993606 |
| 21 | GRK6 | 1.54598066 |
| 22 | ABL2 | 1.41880128 |
| 23 | STK39 | 1.38084280 |
| 24 | DAPK2 | 1.34974644 |
| 25 | TESK2 | 1.26276978 |
| 26 | MAP4K1 | 1.25004325 |
| 27 | PRKAA2 | 1.23959662 |
| 28 | NEK9 | 1.21498618 |
| 29 | MAP3K7 | 1.21304177 |
| 30 | KDR | 1.18815367 |
| 31 | MAP3K10 | 1.17140910 |
| 32 | ERBB2 | 1.15912183 |
| 33 | JAK2 | 1.15884252 |
| 34 | FGFR2 | 1.15785798 |
| 35 | PDK2 | 1.13568572 |
| 36 | TBK1 | 1.08268829 |
| 37 | MAP3K12 | 1.04818155 |
| 38 | MET | 1.04300100 |
| 39 | STK38L | 0.97297361 |
| 40 | DDR2 | 0.97222125 |
| 41 | MAPK4 | 0.96322684 |
| 42 | RIPK1 | 0.94163509 |
| 43 | JAK1 | 0.92671425 |
| 44 | MAP2K3 | 0.92084003 |
| 45 | MAP3K11 | 0.91005838 |
| 46 | NLK | 0.90971699 |
| 47 | OXSR1 | 0.90679138 |
| 48 | EPHB1 | 0.90030626 |
| 49 | PINK1 | 0.89904814 |
| 50 | MAP3K14 | 0.88348622 |
| 51 | PRKCZ | 0.87386439 |
| 52 | MAP3K3 | 0.84734817 |
| 53 | MAP2K6 | 0.84529231 |
| 54 | MATK | 0.83719338 |
| 55 | PBK | 0.81989369 |
| 56 | CDC42BPA | 0.80260797 |
| 57 | PRKACG | 0.77439847 |
| 58 | MAPK15 | 0.76994684 |
| 59 | CDK6 | 0.76673693 |
| 60 | CSK | 0.75331204 |
| 61 | CAMK2G | 0.74734829 |
| 62 | PRKAA1 | 0.72616440 |
| 63 | DYRK1B | 0.72556265 |
| 64 | MAP2K2 | 0.71624151 |
| 65 | MAPK12 | 0.69361576 |
| 66 | EPHA3 | 0.68048085 |
| 67 | SMG1 | 0.67680305 |
| 68 | FER | 0.67249120 |
| 69 | GSK3A | 0.66315925 |
| 70 | PIK3CA | 0.66065165 |
| 71 | PTK2 | 0.65851961 |
| 72 | IRAK1 | 0.65630175 |
| 73 | WNK4 | 0.62096209 |
| 74 | SGK3 | 0.60636410 |
| 75 | PDPK1 | 0.59620642 |
| 76 | IRAK3 | 0.58891329 |
| 77 | CAMK1D | 0.57628851 |
| 78 | TIE1 | 0.57535561 |
| 79 | PRKG2 | 0.57393197 |
| 80 | MAP2K1 | 0.56583572 |
| 81 | LMTK2 | 0.56268959 |
| 82 | PDGFRA | 0.54868782 |
| 83 | SRC | 0.54774433 |
| 84 | IKBKE | 0.54100819 |
| 85 | STK24 | 0.53357849 |
| 86 | GRK1 | 0.51792710 |
| 87 | MAPKAPK3 | 0.51260675 |
| 88 | EEF2K | 0.50946904 |
| 89 | KIT | 0.50595369 |
| 90 | AKT3 | 0.49860930 |
| 91 | MAPK7 | 0.49188650 |
| 92 | PRKCQ | 0.47935291 |
| 93 | ZAP70 | 0.47795656 |
| 94 | ICK | 0.47674574 |
| 95 | FGFR3 | 0.47036063 |
| 96 | MAP3K2 | 0.45793484 |
| 97 | MAP3K5 | 0.43645543 |
| 98 | MAP3K1 | 0.42211442 |
| 99 | CSNK1G1 | 0.42087114 |
| 100 | EPHB2 | 0.42042970 |
| 101 | TGFBR2 | 0.41971623 |
| 102 | TAOK1 | 0.40534126 |
| 103 | MAP3K6 | 0.40346594 |
| 104 | RET | 0.40040658 |
| 105 | IGF1R | 0.39623356 |
| 106 | MAP3K13 | 0.39557612 |
| 107 | TNIK | 0.39018721 |
| 108 | CSF1R | 0.38678876 |
| 109 | RIPK4 | 0.37993061 |
| 110 | TAOK2 | 0.37909951 |
| 111 | PDK1 | 0.36371694 |
| 112 | EPHA4 | 0.36304961 |
| 113 | EPHA2 | 0.34044481 |
| 114 | NUAK1 | 0.33572818 |
| 115 | CDK4 | 0.33498880 |
| 116 | PRKCA | 0.32737111 |
| 117 | SGK2 | 0.32733222 |
| 118 | MYLK | 0.32454254 |
| 119 | PRKACA | 0.31937452 |
| 120 | TESK1 | 0.31018886 |
| 121 | BMX | 0.30566955 |
| 122 | FYN | 0.30248290 |
| 123 | PRKG1 | 0.30192903 |
| 124 | MTOR | 0.29433814 |
| 125 | EGFR | 0.28807531 |
| 126 | CAMK2D | 0.28464429 |
| 127 | PRKCB | 0.26467064 |
| 128 | PDK3 | 0.25562248 |
| 129 | PDK4 | 0.25562248 |
| 130 | CAMK4 | 0.23988682 |
| 131 | PRKCG | 0.23599231 |
| 132 | SGK1 | 0.22883754 |
| 133 | PRKCD | 0.21255894 |
| 134 | KSR2 | 0.21181228 |
| 135 | PIM2 | 0.21015289 |
| 136 | MAPKAPK2 | 0.20522192 |
| 137 | PIM1 | 0.20179676 |
| 138 | SYK | 0.20134724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.33525199 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.53479451 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41503785 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26595080 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.05228534 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70241993 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63048658 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61123983 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53071305 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47198803 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.43781842 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31077950 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29051755 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.20111755 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09237625 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.02584689 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.98960504 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97186112 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.97006448 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.95876732 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91222409 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89760111 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84486127 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.77090146 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75375378 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.69922670 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69495916 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67050110 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.66660888 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64351307 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.60413911 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55220496 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54414089 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.53083748 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52702024 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51953134 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49305461 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43754846 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41396608 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37350864 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36629206 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32189709 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27823592 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27474239 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.22991176 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18518186 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13953130 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.13738546 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12567705 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08137885 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.04534238 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01555284 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99677089 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96403656 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95047531 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94214394 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91561933 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82852257 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79918786 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75109194 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.74928903 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74478569 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74249759 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67119184 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61953189 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52515119 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50212644 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46957293 |
| 69 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44541750 |
| 70 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40090239 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38520682 |
| 72 | Other glycan degradation_Homo sapiens_hsa00511 | 0.36812575 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.34180296 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30876099 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.27431822 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.26397580 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.22115138 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20490357 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19593795 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.13500134 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07888154 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07756485 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.07700786 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.05338327 |
| 85 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02416253 |
| 86 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01553643 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.00091572 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2255710 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2252204 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | -0.2158865 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1957775 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1952455 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1877721 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1839888 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1652032 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1647886 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1549645 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1527451 |
| 99 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1504130 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | -0.1354384 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1302159 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1249833 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1141907 |
| 104 | Allograft rejection_Homo sapiens_hsa05330 | -0.1101691 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1093328 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0924166 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0691676 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0455135 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.0437941 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | -0.0411281 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0147342 |
| 112 | Asthma_Homo sapiens_hsa05310 | -0.0049077 |

